These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 29284300)
1. Stem-Cell Therapy Advances in China. Hu L; Zhao B; Wang S Hum Gene Ther; 2018 Feb; 29(2):188-196. PubMed ID: 29284300 [TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Therapeutic Genome Editing in China. Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996 [TBL] [Abstract][Full Text] [Related]
3. [Historical review of reprogramming and pluripotent stem cell research in China]. Kang L; Chen JY; Gao SR Yi Chuan; 2018 Oct; 40(10):825-840. PubMed ID: 30369467 [TBL] [Abstract][Full Text] [Related]
5. Stem Cell Therapy for Neonatal Disorders: Prospects and Challenges. Chang YS; Ahn SY; Sung S; Park WS Yonsei Med J; 2017 Mar; 58(2):266-271. PubMed ID: 28120555 [TBL] [Abstract][Full Text] [Related]
6. Stem cell-based therapy and regenerative approaches to diseases of the respiratory system. Jungebluth P; Macchiarini P Br Med Bull; 2011; 99():169-87. PubMed ID: 21725086 [TBL] [Abstract][Full Text] [Related]
8. Trends and Prospects of Stem Cell Research in China. Cao JW; Zhang L; Li Y; Yang Q; Fu WH; Wang XC; Huang WL Chin Med Sci J; 2016 Jun; 31(2):116-120. PubMed ID: 28031100 [TBL] [Abstract][Full Text] [Related]
9. Gene Therapy for Hemophilia and Duchenne Muscular Dystrophy in China. Liu X; Liu M; Wu L; Liang D Hum Gene Ther; 2018 Feb; 29(2):146-150. PubMed ID: 29366352 [TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells. Kim EJ; Kang KH; Ju JH Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282 [TBL] [Abstract][Full Text] [Related]
11. Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside. Yim R Transfusion; 2005 Oct; 45(4 Suppl):144S-58S. PubMed ID: 16181400 [TBL] [Abstract][Full Text] [Related]
12. Sorting Out the Best: Enriching Hematopoietic Stem Cells for Gene Therapy and Editing. Radtke S; Humbert O; Kiem HP Mol Ther; 2018 Oct; 26(10):2328-2329. PubMed ID: 30220614 [No Abstract] [Full Text] [Related]
13. In utero stem cell and gene therapy: current status and future perspectives. Loukogeorgakis SP; Flake AW Eur J Pediatr Surg; 2014 Jun; 24(3):237-45. PubMed ID: 24945440 [TBL] [Abstract][Full Text] [Related]
14. [The future of new therapies in clinical medicine]. Gálvez P; Ruiz A; Clares B Med Clin (Barc); 2011 Nov; 137(14):645-9. PubMed ID: 21397281 [TBL] [Abstract][Full Text] [Related]
15. Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier. Papapetrou EP Adv Exp Med Biol; 2017; 1013():219-240. PubMed ID: 29127683 [TBL] [Abstract][Full Text] [Related]
16. Gene and stem cell therapy for diabetes. Calne RY; Ghoneim MA; Lee KO; Uin GS Clin Transpl; 2013; ():111-2. PubMed ID: 25095498 [TBL] [Abstract][Full Text] [Related]